1. Home
  2. VERU vs POCI Comparison

VERU vs POCI Comparison

Compare VERU & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

SELL

Current Price

$2.09

Market Cap

41.9M

Sector

Health Care

ML Signal

SELL

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

SELL

Current Price

$5.11

Market Cap

47.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VERU
POCI
Founded
1971
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
47.8M
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
VERU
POCI
Price
$2.09
$5.11
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $25.67
N/A
AVG Volume (30 Days)
★ 106.8K
19.2K
Earning Date
12-16-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 49.41
EPS
★ N/A
N/A
Revenue
$16,296,958.00
★ $31,531,765.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.31
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 65.16
52 Week Low
$2.04
$3.55
52 Week High
$7.33
$6.15

Technical Indicators

Market Signals
Indicator
VERU
POCI
Relative Strength Index (RSI) 40.86 56.87
Support Level $2.09 $4.89
Resistance Level $2.68 $5.34
Average True Range (ATR) 0.11 0.34
MACD 0.00 0.04
Stochastic Oscillator 26.67 45.21

Price Performance

Historical Comparison
VERU
POCI

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: